Meet Our Team
From Hong Kong, China, Europe, US, and the Middle East, Rejuve Team Members are passionate about AI, blockchain, longevity science and the opportunity to improve people’s lives. We bring together decades of experience in AI, medicine, bioinformatics and international business to provide a world-class team in pursuit of longevity.
Dr. Dominic Man-Kit Lam
Chairman & Chief Biomedical Officer
An acclaimed scientist, philanthropist, award-winning artist, educator, medical professor and entrepreneur, Lam obtained his master and doctorate degrees by age 22. Lam studied under two Nobel Laureates at Harvard Medical School before working as a Professor of Ophthalmology at Houston’s Center for Biotech. Lam is a co-founder of Project Orbis, the charitable ophthalmic airplane, and World Eye Organization to prevent and treat eye diseases for the poor.
Amongst Lam’s achievements: NASDAQ listing of the first Texan biotech company to gain acclaim as “The Father of Texas Biotechnology”, founding director of Hong Kong Institute of Biotechnology, Asia Society Man of the Year, US High Tech Entrepreneur of the Year and recipient of the US Presidential Medal of Merit.
Lam founded LifeTech Group to market a range of healthcare products and his patent on “Edible Vaccine” was named by MIT as one of “five patents that will transform business and technology” and by Time Magazine as one of ten most important inventions in this century.
One of China’s leading artists, Lam received the Prix de Honor for his Dove of Peace statues exhibited at the Louvre Museum in Paris.
Chief Data Scientist
Seid is an experienced software developer with experience designing and coding advanced data structures and algorithms on the OpenCog AGI platform.
Dr. Krešimir Pavelić
Chairman of the Scientific Advisory Board
Pavelic is a highly accomplished medical practitioner, researcher and professor of molecular biology medicine (currently Dean of Medicine at University Juraj Dobrilla in Pula). Born in Croatia, Pavelic’s medical credential are deep and varied. Pavelic is renowned for his contribution to the understanding of biology of transformed cells and the development of new drugs and medical devices.
Pavelic’s international and national scientific work includes: Secretary Genera of the European Molecular Biology Conference and memberships in esteemed bodies like EMBO, European Academy of Sciences and Arts, Croatian Academy of Sciences and Arts, the Standing Committee of the European Medical Research Council, European Science Foundation and European Association for Cancer Research.
Pavelic has published 300 scientific papers and chapters to top journals, review papers, prestigious journals and books published by American and European publishers.
and holds international and national honors and awards. Pavelic has been a plenary speaker in 200 international scientific conferences and mentor for over 85 master and doctoral thesis.
Michael John Duncan
Network Advisor and Medical AI Expert
Duncan is an experienced medical researcher at the intersection of AI and bioinformatics. Chief Computational Biologist at MOZI AI Health, Duncan has a BA in applied mathematics from UC Berkeley, an MPH in epidemiology from SUNY Downstate, and is a licensed physician assistant in New York where he completed a fellowship in orthopedic surgery at Lincoln Hospital.
Duncan managed a consulting service that developed and implemented public health interventions and low-threshold clinical services for underserved populations, with customers including social service NGOs and the New York City Department of Health. Duncan’s research work applying evolutionary programming and probabilistic reasoning to genetics data from super centenarians and nonagenarians is at the cutting edge of AI-driven longevity bioinformatics.
Zaitlick is a long-time partner of the Singularity Group and the Founder and CEO of MOZI AI, an AI bioinformatics company that creates software for the development of regenerative medicine and novel therapeutics for age-related disease.
Founder of Pierce Surgical, Pierce is a medical entrepreneur active in university and private sector research involving products and therapies for tissue engineering, stem cell biology and regenerative medicine.